Regulatory Timeline Expectations for Post-Approval Expiry Changes
Post-approval changes to a drug’s shelf life require submission to regulatory agencies through variation or supplement pathways. Pharma companies must anticipate and align with agency-specific review timelines to prevent disruption in product availability and regulatory compliance. This guide provides a breakdown of expected timelines, regulatory clocks, and best practices for handling expiry date changes globally….
Read More “Regulatory Timeline Expectations for Post-Approval Expiry Changes” »